United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Healthcare Industry News Hormone therapy company BioTE to go public in $737m SPAC deal BioTE Holdings, a US-based hormone therapy company, has agreed to merge with blank check company Haymaker Acquisition Corp.… byPallavi MadhirajuDecember 14, 2021